Literature DB >> 22982125

A comparison of four sputum pre-extraction preparation methods for identifying and characterising Mycobacterium tuberculosis using GCxGC-TOFMS metabolomics.

Johannes C Schoeman1, Ilse du Preez, Du Toit Loots.   

Abstract

In many pulmonary diseases, sputum is a valuable sample material for use in disease characterisation and diagnostics. However, due to its high viscosity and uneven consistency (lumpiness), it is difficult to obtain reproducible/repeatable results during compound extraction and analysis. We subsequently investigated and compared four sputum pre-extraction preparation methods using: 1) Sputolysin; 2) a combination of N-acetyl-l-cysteine and sodium hydroxide (NALC-NaOH); 3) NaOH alone, and 4) a simple ethanol homogenisation method, prior to sputum extraction and metabolomics analyses. The simple ethanol homogenisation approach proved to be the comparatively superior sputum pre-extraction preparation method, considering its repeatability, the number of characteristic compounds extracted, its ability to extract those compounds best differentiating the sample groups (Mycobacterium tuberculosis-spiked and clinically confirmed TB-positive patient samples from each of the controls respectively), and its detection limit. This developed methodology subsequently allows for accurate GC based analyses of sputum, and hence, could contribute significantly to the better characterisation or diagnostics of not only tuberculosis, but also potentially other pulmonary diseases, including, interstitial lung disease, cystic fibrosis, lung cancer, pneumonia and any other bacterial induced pulmonary diseases producing sputum.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22982125     DOI: 10.1016/j.mimet.2012.09.002

Source DB:  PubMed          Journal:  J Microbiol Methods        ISSN: 0167-7012            Impact factor:   2.363


  9 in total

Review 1.  Metabolomics: Applications and Promise in Mycobacterial Disease.

Authors:  Mehdi Mirsaeidi; Mohammad Mehdi Banoei; Brent W Winston; Dean E Schraufnagel
Journal:  Ann Am Thorac Soc       Date:  2015-09

2.  An altered Mycobacterium tuberculosis metabolome induced by katG mutations resulting in isoniazid resistance.

Authors:  Du Toit Loots
Journal:  Antimicrob Agents Chemother       Date:  2014-01-27       Impact factor: 5.191

3.  Early diagnosis and effective treatment regimens are the keys to tackle antimicrobial resistance in tuberculosis (TB): A report from Euroscicon's international TB Summit 2016.

Authors:  Arundhati Maitra; Tengku Karmila Kamil; Monisha Shaik; Cynthia Amaning Danquah; Alina Chrzastek; Sanjib Bhakta
Journal:  Virulence       Date:  2016-11-04       Impact factor: 5.882

4.  Identification of serum biomarkers for active pulmonary tuberculosis using a targeted metabolomics approach.

Authors:  Yonggeun Cho; Youngmok Park; Bora Sim; Jungho Kim; Hyejon Lee; Sang-Nae Cho; Young Ae Kang; Sang-Guk Lee
Journal:  Sci Rep       Date:  2020-03-02       Impact factor: 4.379

5.  Neutral Desorption Extractive Electrospray Ionization Mass Spectrometry Analysis Sputum for Non-Invasive Lung Adenocarcinoma Detection.

Authors:  Qiaoling Zheng; Jianyong Zhang; Xinchen Wang; Wenxiong Zhang; Yipo Xiao; Sheng Hu; Jianjun Xu
Journal:  Onco Targets Ther       Date:  2021-01-15       Impact factor: 4.147

6.  Novel Potential Diagnostic Serum Biomarkers of Metabolomics in Osteoarticular Tuberculosis Patients: A Preliminary Study.

Authors:  Ximeng Chen; Jingyun Ye; Hong Lei; Chengbin Wang
Journal:  Front Cell Infect Microbiol       Date:  2022-03-25       Impact factor: 5.293

7.  Metabolomics Strategy Assisted by Transcriptomics Analysis to Identify Potential Biomarkers Associated with Tuberculosis.

Authors:  Jiayan Jiang; Zhipeng Li; Cheng Chen; Weili Jiang; Biao Xu; Qi Zhao
Journal:  Infect Drug Resist       Date:  2021-11-15       Impact factor: 4.003

Review 8.  The use of functional genomics in conjunction with metabolomics for Mycobacterium tuberculosis research.

Authors:  Conrad C Swanepoel; Du Toit Loots
Journal:  Dis Markers       Date:  2014-03-18       Impact factor: 3.434

9.  Altered phosphatidylcholines expression in sputum for diagnosis of non-small cell lung cancer.

Authors:  Jianyong Zhang; Jianjun Xu; Haiyan Lu; Jianhua Ding; Dongliang Yu; Penghui Li; Jianwen Xiong; Xingxing Liu; Huanwen Chen; Yiping Wei
Journal:  Oncotarget       Date:  2016-09-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.